| ASSET | QUARTER | % RETURN |
|---|---|---|
AT&T (T) | Q2 2022 | 18.68% |
Monster Beverage (MNST) | Q2 2022 | 15.47% |
Eli Lilly and (LLY) | Q2 2022 | 13.69% |
Texas Pacific Land (TPL) | Q2 2022 | 12.06% |
General Mills (GIS) | Q2 2022 | 11.91% |
Merck (MRK) | Q2 2022 | 11.83% |
Kimberly-Clark (KMB) | Q2 2022 | 10.46% |
Dollar General (DG) | Q2 2022 | 10.29% |
International Business Machines (IBM) | Q2 2022 | 10.21% |
Huntington Ingalls Industries (HII) | Q2 2022 | 9.74% |
Amcor (AMCR) | Q2 2022 | 9.57% |
Cigna (CI) | Q2 2022 | 9.28% |
Erie Indemnity (ERIE) | Q2 2022 | 8.96% |
Vertex Pharmaceuticals (VRTX) | Q2 2022 | 7.74% |
Northrop Grumman (NOC) | Q2 2022 | 7.56% |
Humana (HUM) | Q2 2022 | 7.38% |
McKesson (MCK) | Q2 2022 | 6.63% |
Colgate-Palmolive (CL) | Q2 2022 | 6.25% |
Waters (WAT) | Q2 2022 | 6.02% |
Bristol-Myers Squibb (BMY) | Q2 2022 | 5.94% |
Exxon Mobil (XOM) | Q2 2022 | 5.52% |
Super Micro Computer (SMCI) | Q2 2022 | 5.35% |
Gilead Sciences (GILD) | Q2 2022 | 5.29% |
Philip Morris International (PM) | Q2 2022 | 5.29% |
Genuine Parts (GPC) | Q2 2022 | 5.25% |
